Inventor · disambiguated record
Jeffrey Tyner
Also filed as: TYNER JEFFREY · TYNER JEFFREY W
4 granted patents·10 pending applications·4 citations·filing 2008–2023
63Inventor score
Top patents by PatentIndex Score
14 records- 0186US10927418B2Assays and methods for selecting a treatment regimen for a subject with leukemiaCELATOR PHARMACEUTICALS INC·Filed 2016·Granted Feb 23, 2021·3 cites·5 claims
- 0284US11746386B2Assays and methods for selecting a treatment regimen for a subject with leukemiaCELATOR PHARMACEUTICALS INC·Filed 2021·Granted Sep 5, 2023·1 cites·8 claims
- 0375US2023279503A1Assays and methods for selecting a treatment regimen for a subject with leukemiaCELATOR PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0466US2022280519A1Combinations of agents to treat hematological malignanciesUNIV OREGON HEALTH & SCIENCE·Filed 2022·Application pending·0 cites
- 0564US2014303180A1METHODS OF DIAGNOSING AND TREATING aCML and CNLUNIV OREGON HEALTH & SCIENCE·Filed 2014·Application pending·0 cites
- 0663US2014303181A1METHODS OF DIAGNOSING AND TREATING aCML and CNLUNIV OREGON HEALTH & SCIENCE·Filed 2014·Application pending·0 cites
- 0758US2025368655A1Small molecule inhibitors of bcr-ablUNIV OREGON HEALTH & SCIENCE·Filed 2023·Application pending·0 cites
- 0856US2017044625A1METHODS OF DIAGNOSING AND TREATING aCML and CNLUNIV OREGON HEALTH & SCIENCE·Filed 2016·Application pending·0 cites
- 0954US2009312194A1Selection of personalized cancer therapy regimens using interfering rna functional screeningUNIV OREGON HEALTH & SCIENCE·Filed 2008·Application pending·0 cites
- 1052US12268690B2Treatments for mutations in acute myeloid leukemiaUNIV OREGON HEALTH & SCIENCE·Filed 2019·Granted Apr 8, 2025·0 cites·5 claims
- 1151US2020054639A1Combinations of agents to treat hematological malignanciesUNIV OREGON HEALTH & SCIENCE·Filed 2017·Application pending·0 cites
- 1248US2021353619A1Treatment for venetoclax-resistant and venetoclax-sensitive acute myeloid leukemiaUNIV OREGON HEALTH & SCIENCE·Filed 2019·Application pending·0 cites
- 1340US12472175B2Methods of treating venetoclax-resistant acute myeloid leukemiaUNIV OREGON HEALTH & SCIENCE·Filed 2020·Granted Nov 18, 2025·0 cites·13 claims
- 1437US2013131139A1Ror1 as a gene target in acute lymphoblastic leukemiaTYNER JEFFREY W·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey Tyner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →